This inventor holds 1 USPTO granted patent. Top assignee: Medical Research Council. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Phillip Brook-Carter
Introduction
Phillip Brook-Carter is a notable inventor based in Wonthaggi, Australia. He has made significant contributions to the field of medical research, particularly in understanding and diagnosing tuberous sclerosis. His work has implications for both patients with the disorder and the broader medical community.
Latest Patents
Phillip Brook-Carter holds a patent for the "Tuberous sclerosis 2 gene and uses thereof." Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by the widespread development of growths in various tissues and organs. The gene (TSC2) identified on chromosome 16 is mutated in TSC and may function as a tumor suppressor. Screening actual or suspected TSC patients for normal or mutated TSC2 can be utilized for diagnostic purposes. The TSC2 protein, known as tuberin, may be employed to treat or prevent unrestrained cell division and/or tumor development in patients with or without TSC.
Career Highlights
Phillip Brook-Carter is affiliated with the Medical Research Council, where he continues to advance research in his field. His work has been instrumental in enhancing the understanding of genetic factors in tuberous sclerosis and their potential therapeutic applications.
Collaborations
Phillip has collaborated with esteemed colleagues such as Julian R Sampson and Mark David Nellist. Their combined expertise has contributed to the advancement of research in genetic disorders.
Conclusion
Phillip Brook-Carter's innovative work in the field of tuberous sclerosis research highlights the importance of genetic understanding in medical diagnostics and treatment. His contributions continue to impact the lives of many patients and the medical community at large.